Who's buying Alaunos Therapeutics, Inc.?

TCRT insider buying, 13F and 13D filings

• Oct 15, 202613D stake (no activist plan)
  WaterMill Asset Management Corp. (+1): Amended Schedule 13D: 10.0% stake
  View the filing on SEC EDGAR ↗
• Oct 15, 202613D stake (no activist plan)
  Fairmount Funds Management LLC (+4): New Schedule 13D: 20.0% stake
  The Reporting Persons own 19.99% of the Company in the aggregate, based upon the Company's aggregate outstanding shares as of September 30, 2026, plus the shares of Common Stock issued in the Financing (as defined below). The Reporting Persons' securities include (i) 687,789 shar…
  View the filing on SEC EDGAR ↗

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.